tocainide has been researched along with Central Nervous System Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ballantyne, D; Bastian, BC; Clark, P; Hillis, WS; Hutton, I; Macfarlane, PW; McLauchlan, JH; Rae, AP | 1 |
| Mahapatra, D; Mahapatra, RK | 1 |
2 trial(s) available for tocainide and Central Nervous System Disease
| Article | Year |
|---|---|
A prospective randomized trial of tocainide in patients following myocardial infarction.
Topics: Anilides; Arrhythmias, Cardiac; Blood Pressure; Central Nervous System Diseases; Female; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Tocainide | 1980 |
Efficacy and safety of oral tocainide in refractory ventricular arrhythmia: a preliminary report on an open label study.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Central Nervous System Diseases; Clinical Trials as Topic; Drug Eruptions; Electrocardiography; Female; Humans; Lidocaine; Long QT Syndrome; Male; Middle Aged; Tachycardia; Tocainide | 1986 |